Tirzepatide Metabolism: Half-Life and Steady State at 2.5 mg

Wed, 03 Dec 2025 16:09:26 +0000

Tirzepatide, the active ingredient in Mounjaro KwikPen 2.5 mg, is one of the most advanced medications available for type 2 diabetes and weight loss. Its dual action on GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors makes it more effective than traditional GLP-1 agonists.